Initial Clinico-Biological Characteristics and Follow-up Data of Elderly Patients With Chronic Lymphocytic Leukemia (CLL): A Retrospective Analysis of a Series of 364 Cases

被引：1

作者：

Baumann, Tycho ^{[1
,2
]}

Delgado, Julio ^{[1
]}

Santacruz, Rodrigo ^{[1
]}

Martinez-Trillos, Alejandra ^{[1
,2
]}

Royo, Cristina ^{[2
]}

Navarro, Alba ^{[2
]}

Pinyol, Magda ^{[2
]}

Rozman, Maria ^{[2
]}

Villamor, Neus ^{[2
]}

Aymerich, Marta ^{[2
]}

Carrio, Anna ^{[2
]}

Montserrat, Emil ^{[1
]}

机构：

[1] Univ Barcelona, Inst Hematol & Oncol, Dept Hematol, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain

[2] Univ Barcelona, Hematopathol Unit, Dept Pathol, Hosp Clin,IDIBAPS, Barcelona, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷

关键词：

D O I：

10.1016/j.clml.2014.06.056

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

301

引用

页码：S129 / S130

页数：2

共 50 条

[21] LONG-TERM FOLLOW-UP DATA SUPPORT THE CURATIVE POTENTIAL OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE ANALYSIS FROM THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT
van Gelder, M.
de Wreede, L.
Henseler, A.
van Biezen, A.
Niederwieser, D.
Karas, M.
Andersen, N. S.
Gramatzki, M.
Dreger, P.
Bunjes, D.
Petersen, E.
Potter, M.
Beelen, D.
Yakoub-Agha, I.
Cornelissen, J. J.
Russell, N. H.
Finke, J.
Maertens, J.
Blaise, D.
Paneesha, S.
Vitek, A.
Bornhaeuser, M.
Schoenland, S.
Kroeger, N.
Schetelig, J.
BONE MARROW TRANSPLANTATION, 2014, 49 : S34 - S34
[22] Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and Relapsed/Refractory (R/R) Patients with Chronic Lymphocytic Leukemia (CLL): 3-Year Follow-Up
Woyach, Jennifer A.
Rogers, Kerry A.
Bhat, Seema
Blachly, James
Jianfar, Mojgan
Frigault, Melanie M.
Hamdy, Ahmed
Izumi, Raquel
Munugalavadla, Veerendra
Quah, Cheng
Wang, Min Hui
Byrd, John C.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S281 - S281
[23] Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis
Eichhorst, Barbara F.
Fischer, Kirsten
Fink, Anna-Maria
Elter, Thomas
Wendtner, Clemens M.
Goede, Valentin
Bergmann, Manuela
Stilgenbauer, Stephan
Hopfinger, Georg
Ritgen, Matthias
Bahlo, Jasmin
Busch, Raymonde
Hallek, Michael
BLOOD, 2011, 117 (06) : 1817 - 1821
[24] Final Analysis From RESONATE: Six-Year Follow-Up in Patients With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma on Ibrutinib
O'Brien, Susan M.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (07) : 11 - 13
[25] Cladribine Alone and in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Long-Term Follow-up of the the Polish Adult Leukemia Group (PALG CLL2) Study
Robak, Tadeusz
Blonski, Jerzy
Jamroziak, Krzysztof
Calbecka, Malgorzata
Dwilewicz-Trojaczek, Jadwiga
Boguradzki, Piotr
Dmoszynska, Anna
Kowal, Malgorzata
Kloczko, Janusz
Piszcz, Jaroslaw
Stella-Holowiecka, Beata
Sulek, Kazimierz
Kuliczkowski, Kazimierz
Potoczek, Stanislaw
Warzocha, Krzysztof
Lech-Maranda, Ewa
Skotnicki, Aleksander
Magdalena, Piotrowska
Moskwa, Andrzej
Zawilska, Krystyna M.
Gora-Tybor, Joanna
BLOOD, 2011, 118 (21) : 1674 - 1675
[26] PROGRESSIVE TELOMERE SHORTENING IS PART OF THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND IMPACTS CLINICAL OUTCOME: EVIDENCES FROM A STUDY ON PATIENTS WITH A LONG TERM FOLLOW-UP
Genuardi, E.
Ghione, P.
Rossi, D.
Drandi, D.
Mantoan, B.
Barbero, D.
Bernocco, E.
Monitillo, L.
Cerri, M.
Ruggeri, M.
Omede, P.
Deambrogi, L.
De Paoli, L.
Passera, R.
Coscia, M.
Cavallo, F.
Massaia, M.
Boccadoro, M.
Gaidano, G.
Ladetto, M.
Ferrero, S.
HAEMATOLOGICA, 2016, 101 : S23 - S24
[27] Final Analysis of the RESONATE-2 Study: up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Burger, Jan
Barr, Paul
Robak, Tadeusz
Owen, Carolyn
Tedeschi, Alessandra
Sarma, Anita
Patten, Piers E. M.
Grosicki, Sebastian
McCarthy, Helen
Offner, Fritz
Szafer-Glusman, Edith
Zhou, Cathy
Szoke, Anita
Neumayr, Lynne
Dean, James P.
Ghia, Paolo
Kipps, Thomas J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S342 - S343
[28] Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial
Shanafelt, Tait D.
Wang, Victoria
Kay, Neil E.
Hanson, Curtis A.
O'Brien, Susan M.
Barrientos, Jacqueline C.
Jelinek, Diane F.
Braggio, Esteban
Leis, Jose F.
Zhang, Cong Christina
Coutre, Steven
Barr, Paul M.
Cashen, Amanda F.
Mato, Anthony R.
Singh, Avina
Mullane, Michael P.
Little, Richard F.
Erba, Harry P.
Stone, Richard M.
Litzow, Mark
Tallman, Martin S.
BLOOD, 2019, 134
[29] Clinical Characteristics and Treatment Choices in Previously Untreated Elderly Patients (≥65 Years) With Chronic Lymphocytic Leukemia (CLL): Interim Analysis of the informCLL Real-World Registry
Ghosh, Nilanjan
Barrientos, Jacqueline C.
Brander, Danielle
Gutierrez, Meghan
Ipe, David
Iyengar, Reethi
Arango-Hisijara, Israel
He, Jinghua
Huang, Qing
Han, Jennifer
Sharman, Jeff P.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S224 - S224
[30] Consequences of a stay in the intensive care unit and outpatient follow-up care for chronic critically ill patients: A retrospective data analysis
Maurer, Carol
Exl, Matthias Thomas
Gander, Hans-Peter
Bertschi, Daniela
Fischbacher, Irene
Barbezat, Isabelle
Eissler, Christian
Jeitziner, Marie-Madlen
AUSTRALIAN CRITICAL CARE, 2024, 37 (06) : 931 - 939

← 1 2 3 4 5 →